Results 271 to 280 of about 251,175 (335)

Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes

British Journal of Haematology, EarlyView.
A retrospective study from 11 institutions was performed in 139 chronic myeloid leukaemia (CML) patients with secondary malignancies. The median ages at diagnosis of CML and secondary malignancy were 51 years (range, 13–88 years) and 53 years (range, 18–91 years). After a median follow‐up of 85 months, the median time from diagnosis of CML to secondary
Yingling Zu, Xipeng Yue, Xinrong Zhan, Xiaojuan Liu, Hongxia Ma, Fuli Qin, Lijuan Duan, Hongmian Zhao, Yan Zhang, Shiqiang He, Huifang Zhao, Chunlei Zhang, Xiangke Xin, Wenli Zhang, Yongping Song, Bingcheng Liu, Weiming Li, Yanli Zhang   +17 more
wiley   +1 more source

Optimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium. [PDF]

Iran Biomed J
Ghobadian H, Roshanzamir K, Kouhi Abdolabadi M, Ostadi H, Zati Keikha R, Dolatkhah Baghan M, Talebkhan Y, Torkashvand F.   +7 more
europepmc   +1 more source

Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population‐based cohort study

British Journal of Haematology, EarlyView.
Treatment‐related infertility is of great concern to younger long‐term survivors of acute leukaemia (AL). The literature on fertility outcomes in adult long‐term AL survivors is limited, mainly focused on stem cell transplantation or childhood leukaemia, with little information on the use of assisted reproduction technology.
Nanna N. Nielsen, Jonas F. Jensen, Andreas Øvlisen, Ditte R. Zenas, Claudia Schöllkopf, Nina Toft, Andreas D. Ørskov, Dennis L. Hansen, Ingolf Mølle, Daniel T. Kristensen, Marianne T. Severinsen   +10 more
wiley   +1 more source

Expression and functional characterization of chimeric recombinant bovine follicle-stimulating hormone produced in Leishmania tarentolae. [PDF]

Microb Biotechnol
Abreu C, Grunberg K, Bonilla M, Crispo M, Pantano S, Jaeschke J, Comini MA, Bollati-Fogolín M.   +7 more
europepmc   +1 more source

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

Clinical Endocrinology, EarlyView.
ABSTRACT Context Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian ...
Yasir S. Elhassan, James M. Hawley, Leanne Cussen, Ali Abbara, Sophie A. Clarke, Punith Kempegowda, Rima K. Dhillon‐Smith, Puja Thadani, Maureen Busby, Lucy Owusu‐Darkwah, Rachel Marrington, W. Colin Duncan, Robert K. Semple, Richard Quinton, Michael W. O'Reilly   +14 more
wiley   +1 more source

Development of a predictive nomogram for testicular sperm extraction outcomes in patients with non-obstructive azoospermia using testicular volume, follicle-stimulating hormone levels, and testosterone levels as key parameters. [PDF]

Transl Androl Urol
Zhou Q, Mao C, Ouyang J, Zhang Z.
europepmc   +1 more source

The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics‐Treated Men With Hyperprolactinemia and Early‐Onset Androgenic Alopecia

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Metformin decreases elevated levels of pituitary hormones. Little is known about the association between the reproductive axis and hormonal effects of this drug. The purpose of our study was to investigate whether activity of the hypothalamic‐pituitary‐gonadal axis determines metformin action on prolactin levels in men with prolactin
Robert Krysiak, Karolina Kowalcze, Marek Krzystanek, Witold Szkróbka, Bogusław Okopień   +4 more
wiley   +1 more source

Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two‐Step Approach

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Calcitonin (CT) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. Procalcitonin (ProCT) has been recognized as an alternative or additional marker for MTC. The aim of the study is to evaluate prospectively the role of ProCT combined with CT in the identification of MTC ...
Cristina Clausi, Simona Censi, Emma Zanin, Giulia Messina, Ilaria Piva, Daniela Basso, Isabella Merante Boschin, Loris Bertazza, Francesca Torresan, Maurizio Iacobone, Fiammetta Battheu, Susi Barollo, Jacopo Maria Arnone, Caterina Mian   +13 more
wiley   +1 more source

Stable Production of a Recombinant Single-Chain Eel Follicle-Stimulating Hormone Analog in CHO DG44 Cells. [PDF]

Int J Mol Sci
Byambaragchaa M, Park SH, Kim SG, Shin MG, Kim SK, Park MH, Kang MH, Min KS.   +7 more
europepmc   +1 more source